研究发现,阻断MARCO蛋白会加强黑瘤治疗,增强对肿瘤的免疫反应。 Study finds blocking MARCO protein enhances melanoma treatment, boosting immune response against tumors.

Moffitt癌症中心的研究人员发现,堵塞一种称为MARCO的蛋白质会提高常见的黑素瘤治疗、抗CTLA4疗法的效力。 Researchers at Moffitt Cancer Center found that blocking a protein called MARCO enhances the effectiveness of a common melanoma treatment, anti-CTLA4 therapy. 这种结合增加了免疫细胞进入肿瘤的可能性,有可能克服难以治疗的“冷”肿瘤的耐药性。 This combination increases immune cell entry into tumors, potentially overcoming resistance in hard-to-treat "cold" tumors. 研究表明,这种方法可以减少癌症的复发,并为目前对免疫疗法不作反应的病人带来新的希望。 The study suggests this approach could reduce cancer recurrence and offers new hope for patients not responding to current immunotherapies.